Conmed (CNMD) Gross Profit (2010 - 2026)

Conmed (CNMD) has 17 years of Gross Profit data on file, last reported at $183.4 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit rose 3.2% year-over-year to $183.4 million; the trailing twelve-month figure through Mar 2026 stood at $756.2 million (up 2.35% YoY), and the FY2025 full-year result was $750.5 million, up 2.38% from the prior year.
• Gross Profit for Q1 2026 stood at $183.4 million, down from $218.3 million in the prior quarter.
• Across five years, Gross Profit topped out at $218.3 million in Q4 2025 and bottomed at $131.9 million in Q4 2022.
• The 5-year median for Gross Profit is $172.0 million (2024), against an average of $171.4 million.
• The widest annual swing landed in 2022, when Gross Profit fell 15.39%; it then surged 38.16% in 2023.
• A 5-year view of Gross Profit shows it stood at $131.9 million in 2022, then soared by 38.16% to $182.2 million in 2023, then advanced by 8.88% to $198.3 million in 2024, then rose by 10.05% to $218.3 million in 2025, then slipped by 15.96% to $183.4 million in 2026.
• The last three Gross Profit figures came in at $183.4 million (Q1 2026), $218.3 million (Q4 2025), and $166.1 million (Q3 2025), per Business Quant data.

Peer Comparison